We demonstrate that, although chemotherapy eliminates most malignant cells, CSCs defined by high ALDH1 activity are left behind in tumors with limited chemotherapeutic response and poor prognosis indicating their pronounced ability to re-initiate cancer. This evidence concerns the gene ALDH1A1 and cancer.